NLM Logo

Inotuzumab Ozogamicin MeSH Descriptor Data 2021


MeSH Heading
Inotuzumab Ozogamicin
Tree Number(s)
D09.408.051.247.750
D12.776.124.486.485.114.224.060.794
D12.776.124.790.651.114.224.060.794
D12.776.377.715.548.114.224.200.794
Unique ID
D000080045
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000080045
Scope Note
Immunotoxin that consists of anti-CD22 (CD22 ANTIGEN) humanized monoclonal antibody covalently linked to the antineoplastic antibiotic CALICHEAMICIN. It is used for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (LEUKEMIA, ACUTE LYMPHOBLASTIC).
Entry Term(s)
Besponsa
CMC-544
CMC544
Pharm Action
Antineoplastic Agents, Immunological
Antibiotics, Antineoplastic
Immunotoxins
Registry Number
P93RUU11P7
Public MeSH Note
2020; INOTUZUMAB OZOGAMICIN was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2019 and under ANTIBODIES, MONOCLONAL (2004-2011)
History Note
2020 (2004)
Date Established
2020/01/01
Date of Entry
2019/07/08
Revision Date
2019/01/16
Inotuzumab Ozogamicin Preferred
Besponsa Narrower
CMC544 Narrower
page delivered in 0.145s